| Annual Report |
|
| 2000-2001 | |
|
Features: Academia and Industry Working Together for Biomedical Advances WSU Considered Model Program in Prenatal Genetic Analysis WSU Gets Early Access to Corning Technologies Dr. Joan Dunbar: Research Matchmaker Best Oncology Practices Standardized by Innovative Solutions Freezing the Deadly Spread of Cancer Combining Technology and Expertise to Discover New Genes in Epilepsy General Motors Supports Prevention Program Cell Therapy Center Advances Immunotherapies for Clinical Application |
Academia And Industry: Working Together For Biomedical Advances
Traditionally, research universities have immersed themselves in the creation of knowledge, while corporations have been concerned solely with the creation of profit. Those missions were clear cut and rarely did they intersect—until now.
Biomedical research has become big business. In fiscal year 2001, the National Institutes of Health (NIH) is expected to spend approximately $20 billion on research. For the past three years, the NIH has consistently received appropriation increases indicating strong public support for the future of medical research and advancement. At the same time, the Pharmaceutical Research and Manufacturers of America reports that drug industry expenditures for research and development will reach nearly $26.4 billion. With this sort of investment in disease prevention and therapy, it is in WSU’s best interest to compete aggressively for available funds. Although universities have always functioned as the creators of knowledge, academic researchers have not traditionally viewed their work as business ventures or potential sources of profit. As the Wayne State University School of Medicine competes for more public and private research funding, it is looking to industry to create resourceful collaborations. As large companies concentrate on applied research, they often look to universities to complete basic research. In the past year, many faculty members at WSU have lent their expertise to research projects in early development stages. In the meantime, companies monitor that work, watching for a potential investment. Such investments in academic research have proven fruitful, resulting in new products that improve health, quality of life and the environment. On the following pages are just a handful of examples pointing to Wayne State University’s active role in pursuing patents, licensing rights and technology transfers. These partnerships between academia and industry have the strength and potential to bring many new medical advances to the forefront with the WSU School of Medicine paving the way. |
2000
Report to Investors: The Quest to Improve Women's Health Gifts from Faculty, Staff, Friends and Corporations 2000/2001 Alumni Annual Telefund Volunteers 2000 New Endowed Funds at the School of Medicine Bibliographies: Barbara Ann Karmanos Cancer Institute Biochemistry and Molecular Biology Center for Healthcare Effectiveness Research Center for Molecular Medicine and Genetics Physical Medicine and Rehabilitation |